News

Plants get a GMO glow-up

Genetically modified varieties are coming out of the lab and into homes and gardens
James W. Satterlee
By James W. Satterlee
Nov. 10, 2024

As any avid gardener will tell you, plants with sharp thorns and prickles can leave you looking like you’ve had a run-in with an angry cat. Wouldn’t it be nice to rid plants of their prickles entirely but keep the tasty fruits and beautiful flowers?

Not every rose has its thorn, thanks to gene editing.
James Satterlee, CC BY-SA
Not every rose has its thorn, thanks to gene editing.

I’m a geneticist who, along with my colleagues, recently discovered the gene that accounts for prickliness across a variety of plants, including roses, eggplants and even some species of grasses. Genetically tailored, smooth-stemmed plants may eventually arrive at a garden center near you.

Acceleration of nature

Plants and other organisms evolve naturally over time. When random changes to their DNA, called mutations, enhance survival, they get passed on to offspring. For thousands of years, plant breeders have taken advantage of these variations to create high-yielding crop varieties.

In 1983, the first genetically modified organisms, or GMOs, appeared in agriculture. Golden rice, engineered to combat vitamin A deficiency, and pest-resistant corn are just a couple of examples of how genetic modification has been used to enhance crop plants.

Two recent developments have changed the landscape further. The advent of gene editing using a technique known as CRISPR has made it possible to modify plant traits more easily and quickly. If the genome of an organism were a book, CRISPR-based gene editing is akin to adding or removing a sentence here or there.

This tool, combined with the increasing ease with which scientists can sequence an organism’s complete collection of DNA – or genome – is rapidly accelerating the ability to predictably engineer an organism’s traits.

By identifying a key gene that controls prickles in eggplants, our team was able to use gene editing to mutate the same gene in other prickly species, yielding smooth, prickle-free plants. In addition to eggplants, we got rid of prickles in a desert-adapted wild plant species with edible raisin-like fruits.

The desert raisin (Solanum cleistogamum) gets a makeover.
Blaine Fitzgerald, CC BY-SA
The desert raisin (Solanum cleistogamum) gets a makeover.

We also used a virus to silence the expression of a closely related gene in roses, yielding a rose without thorns.

In natural settings, prickles defend plants against grazing herbivores. But under cultivation, edited plants would be easier to handle – and after harvest, fruit damage would be reduced. It’s worth noting that prickle-free plants still retain other defenses, such as their chemical-laden epidermal hairs called trichomes that deter insect pests.

From glowing petunias to purple tomatoes

Today, DNA modification technologies are no longer confined to large-scale agribusiness – they are becoming available directly to consumers.

One approach is to mutate certain genes, like we did with our prickle-free plants. For example, scientists have created a mild-tasting but nutrient-dense mustard green by inactivating the genes responsible for bitterness. Silencing the genes that delay flowering in tomatoes has resulted in compact plants well suited to urban agriculture.

Another modification approach is to permanently transfer genes from one species to another, using recombinant DNA technology to yield what scientists call a transgenic organism.

The firefly petunia is genetically engineered to glow in the dark.
The firefly petunia is genetically engineered to glow in the dark.

At a recent party, I found myself crowded into a darkened bathroom to observe the faint glow of the host’s newly acquired firefly petunia, which contains the genes responsible for the ghost ear mushroom’s bioluminescent glow. Scientists have also modified a pothos houseplant with a gene from rabbits, which allows it to host air-filtering microbes that promote the breakdown of harmful volatile organic compounds, or VOCs.

Consumers can also grow the purple tomato, genetically engineered to contain pigment-producing genes from the snapdragon plant, resulting in antioxidant-rich tomatoes with a dark purple hue.
Norfolk Healthy Produce, CC BY-SA
The Norfolk purple tomato is colorful to the core.

Consumers can also grow the purple tomato, genetically engineered to contain pigment-producing genes from the snapdragon plant, resulting in antioxidant-rich tomatoes with a dark purple hue.

Risks and rewards

The introduction of genetically modified plants into the consumer market brings with it both exciting opportunities and potential challenges.

With genetically edited plants in the hands of the public, there could be less oversight over what people do with them. For instance, there is a risk of environmental release, which could have unforeseen ecological consequences. Additionally, as the market for these plants expands, the quality of products may become more variable, necessitating new or more vigilant consumer protection laws. Companies could also apply patent rules limiting seed reuse, echoing some of the issues seen in the agricultural sector.

The future of plant genetic technology is bright – in some cases, quite literally. Bioluminescent golf courses, houseplants that emit tailored fragrances or flowers capable of changing their color in response to spray-based treatments are all theoretical possibilities. But as with any powerful technology, careful regulation and oversight will be crucial to ensuring these innovations benefit consumers while minimizing potential risks.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

The Conversation

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
James W. Satterlee
James W. Satterlee

James W. Satterlee is a postdoctoral fellow in plant genetics at Cold Spring Harbor Laboratory.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Uncovering the mechanisms of a glycosylation disorder
Journal News

Uncovering the mechanisms of a glycosylation disorder

March 27, 2026

Mutations in OGT, an enzyme that adds sugars to proteins, cause a rare neurological disorder. Using proteomics, researchers reveal how OGT interactions with TET proteins may trigger epigenetic changes and early neural defects.

Heat shock proteins as a promising breast cancer therapeutic
Journal News

Heat shock proteins as a promising breast cancer therapeutic

March 25, 2026

Researchers unveiled isoform-specific targets on heat shock protein 90 which may be beneficial in therapeutic development.

Optimized proteomic analysis of preserved biological tissue samples
Journal News

Optimized proteomic analysis of preserved biological tissue samples

March 25, 2026

Researchers have developed an optimized workflow for analyzing formalin-fixed paraffin-embedded tissue. This workflow provides an enhanced collection of unique proteins and phosphorylation sites for more detailed analysis of biological samples.

Blood proteomics reveals fungal infection signatures for faster diagnosis
Journal News

Blood proteomics reveals fungal infection signatures for faster diagnosis

March 24, 2026

Whole-blood proteomics identifies more than 3,000 host and 160 fungal proteins during cryptococcal infection, offering potential biomarkers for faster diagnosis and improved monitoring without invasive spinal taps.

When things get SAPpy: Novel insights into complement
Journal News

When things get SAPpy: Novel insights into complement

March 20, 2026

Researchers have defined interactions between an innate immune protein and two of its known binding partners. They identified potential areas of crosstalk between the two binding interactions.

Glutathione pathway implicated in rare disease
Journal News

Glutathione pathway implicated in rare disease

March 19, 2026

Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.